Need a specific person's email?
Browse Basilea Pharmaceutica's employee directory (about 259 employees) and reveal verified emails free.
Basilea Pharmaceutica's most common email format is First.Last@basilea.com (ex. John.Doe@basilea.com), used for 87% of basilea.com addresses. Basilea Pharmaceutica uses 4 email patterns.
| Format | Example | Share of basilea.com |
|---|---|---|
| First.Last@basilea.comMost common | John.Doe@basilea.com | |
| LastF@basilea.com | DoeJ@basilea.com | |
| Last.First@basilea.com | Doe.John@basilea.com | |
| First.Middle@basilea.com | John.Michael@basilea.com |
Browse Basilea Pharmaceutica's employee directory (about 259 employees) and reveal verified emails free.
Biotechnology ResearchBasel-Landschaft, Switzerland201-500 Employees
Basilea Pharmaceutica is a biotechnology research company founded in 2000 and headquartered in the Basel area of Switzerland, at 167b Hegenheimermattweg, Allschwil, Basel-landschaft 4123. It operates as a commercial-stage biopharmaceutical company focused on discovering, developing, and commercializing drugs to address severe bacterial and fungal infections. It has launched two hospital brands, Cresemba for invasive fungal infections and Zevtera for severe bacterial infections. It employs between 201 and 500 people and is listed on the SIX Swiss Exchange (SIX: BSLN); its website is https://basilea.com. It maintains several preclinical anti-infective assets and has pursued collaborations to advance antimicrobial development, including partnerships with Phare Bio and Prokaryotics announced in 2026.
Most common format
First.Last@basilea.com
Example: John.Doe@basilea.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.